Show simple item record

CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas

dc.contributor.authorKuravi, Sudhakiranmayi
dc.contributor.authorParrott, Elizabeth
dc.contributor.authorMudduluru, Giridhar
dc.contributor.authorCheng, Janice
dc.contributor.authorGanguly, Siddhartha
dc.contributor.authorSaunthararajah, Yogen
dc.contributor.authorJensen, Roy A.
dc.contributor.authorBlagg, Brian S.
dc.contributor.authorMcGuirk, Joseph P.
dc.contributor.authorBalusu, Ramesh
dc.date.accessioned2019-09-04T14:56:36Z
dc.date.available2019-09-04T14:56:36Z
dc.date.issued2019-01-29
dc.identifier.citationKuravi, S., Parrott, E., Mudduluru, G. et al. CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas. Blood Cancer Journal 9, 14 (2019). https://doi.org/10.1038/s41408-019-0171-2
dc.identifier.urihttp://hdl.handle.net/1808/29508
dc.descriptionA grant from the One-University Open Access Fund at the University of Kansas was used to defray the author's publication fees in this Open Access journal. The Open Access Fund, administered by librarians from the KU, KU Law, and KUMC libraries, is made possible by contributions from the offices of KU Provost, KU Vice Chancellor for Research & Graduate Studies, and KUMC Vice Chancellor for Research. For more information about the Open Access Fund, please see http://library.kumc.edu/authors-fund.xml.en_US
dc.description.sponsorshipAmerican Cancer Society (ACS-IRG-16-194-07)en_US
dc.publisherSpringer Natureen_US
dc.rightsOpen Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.en_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectT-cell lymphomaen_US
dc.subjectTargeted therapiesen_US
dc.titleCDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomasen_US
dc.typeArticleen_US
kusw.kuauthorBalusu, Ramesh
kusw.kudepartmentInternal Medicine/ KUMCen_US
dc.identifier.doi10.1038/s41408-019-0171-2en_US
dc.identifier.orcidhttps://orcid.org/0000-0003-4430-2281en_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccessen_US


Files in this item

Thumbnail
Name:
Ramesh Balusu.pdf
Size:
897.9Kb
Format:
PDF
Description:
Main Article
View/Open

This item appears in the following Collection(s)

Show simple item record

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Except where otherwise noted, this item's license is described as: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.